<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03018990</url>
  </required_header>
  <id_info>
    <org_study_id>S-20160083</org_study_id>
    <nct_id>NCT03018990</nct_id>
  </id_info>
  <brief_title>Alcohol Challenge On Liver and Gut Measured by Liver Vein Catheterization. A Pathophysiological Intervention Trial</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effects of acute alcohol challenge on the gut and liver axis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To study the role of acute alcohol challenge on the intestine permeability and inflow of
      bacterial products to the liver in participants with alcoholic liver disease, non-alcoholic
      steatohepatitis and healthy controls.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in concentrations of bacterial products in the liver vein</measure>
    <time_frame>Within 24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in concentrations of bacterial products in the peripheral vein system</measure>
    <time_frame>Within 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in the gut microbiome</measure>
    <time_frame>Within 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in the liver metabolome, transcriptome and proteome</measure>
    <time_frame>Within 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in serum-ethanol, plasma-glucose and liver biomarkers in the liver vein compared to the peripheral vein system</measure>
    <time_frame>Within 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Liver Fibroses</condition>
  <condition>Alcohol-Induced Disorders</condition>
  <arm_group>
    <arm_group_label>Alcoholic liver fibrosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-alcoholic steatohepatitis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ethanol</intervention_name>
    <description>1 milliliter per kilogram body weight adjusted for elevated body mass index</description>
    <arm_group_label>Alcoholic liver fibrosis</arm_group_label>
    <arm_group_label>Non-alcoholic steatohepatitis</arm_group_label>
    <arm_group_label>Healthy control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Alcoholic liver fibrosis, non-alcoholic steatohepatitis or liver-healthy individuals

        And all of following:

          -  Bodymass &gt; 50 kg

          -  Able to be fasting and abstinent on the day of intervention

          -  international ratio &lt;1.5 and platelets &gt;100 x 10^9, 7 days before the intervention day

          -  Informed consent

        Exclusion Criteria:

          -  Antibiotics during the last 4 weeks

          -  Total alcohol abstinence

          -  Desire of total alcohol abstinence

          -  Other causes of liver disease suspected (viral, autoimmune, haemochromatosis, Wilsons
             diseases, alfa 1 antitrypsin deficiency or drug induced)

          -  Cirrhosis

          -  Insulin dependent diabetes mellitus

          -  Incapable to follow the protocol instructions

          -  Pregnancy

          -  Primary or secondary liver cancer

          -  Severe comorbidity

          -  Allergic to the contrast media iohexol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aleksander Krag, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor, department of gastroenterology and hepatology, Odense University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mads Israelsen, MD</last_name>
    <phone>+ 45 20681060</phone>
    <email>mads.egerod.israelsen@rsyd.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bjørn Madsen, MD</last_name>
    <email>bjoern.staerh.madsen@rsyd.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <state>Fyn</state>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mads Israelsen, MD</last_name>
      <phone>+ 45 20681060</phone>
      <email>mads.egerod.israelsen@rsyd.dk</email>
    </contact>
    <contact_backup>
      <last_name>Bjørn Madsen, MD</last_name>
      <email>bjoern.staerh.madsen@rsyd.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2017</study_first_submitted>
  <study_first_submitted_qc>January 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2017</study_first_posted>
  <last_update_submitted>January 11, 2017</last_update_submitted>
  <last_update_submitted_qc>January 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Mads Israelsen</investigator_full_name>
    <investigator_title>MD,clinical research assistant, PhD-student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Alcohol-Induced Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

